Open Pharma Members, Supporters and key advisers came together to discuss how medical publication professionals can improve the accessibility and discoverability of scientific research.
Featuring the role of open science in combating the coronavirus outbreak, a new journal ranking system to measure research transparency and highlights from this week’s ISMPP U webinar.
Featuring a summary of a recent study on the compliance of clinical trial reporting under US law, the role of patients in medical publishing, the rising popularity of preprints and an overview of Open Pharma’s activities this week.
Featuring a summary of the updated ICMJE recommendations, the failure of the FDA and the NIH to enforce clinical trial reporting laws, an independent report aiming to improve the transparency of open access services, and the new article format coming to PLOS ONE
Featuring the current predictions for publishing trends in 2020, draft guidance on how to implement the DORA principles in research organizations and a new international observatory to tackle predatory publishers
Featuring Altmetric’s Christmas list, the current status of transformative agreements in relation to Plan S and a review of the ICMJE’s data sharing policy.
Featuring the announcement of the new collaborative service GetFTR, advancements in European policies for open science and digital enhancements in medical publishing
Featuring persistent object identifiers for research organizations, an investigation into the standards of reporting randomized clinical trials, the co-production of scientific research and the development of the next set of Good Publication Practice guidelines.
Featuring the new read-and-publish deal between Elsevier and Carnegie Mellon University, a beta repository for research from UK cultural and heritage organizations and the range of APC across publishers
Featuring highlights from the ISMPP U webinar on plain-language summaries, lessons learned from the YODA Project and the benefits of Wiley’s ‘Under Review’ service.